Kobayashi Pharmaceutical ... (KBYPF)

PNK: KBYPF · Real-Time Price · USD

37.43

2.39 (6.82%)

At close: May 01, 2025, 8:00 PM

Kobayashi Pharmaceutical Income Statement

Financials in JPY. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	51.14B	41.32B	36.65B	36.48B	54.34B	45.49B	40.16B	33.47B	51.98B	43.02B	38.62B	32.65B	47.59B	40.61B	36.78B	30.27B	45.47B	38.87B	34.27B	31.91B	50.26B	44.16B	39.9B	33.73B	51.71B	43.09B	38.96B	33.72B	49.11B	40.35B	36.56B	30.75B	37.6B	36.77B	32.6B
Cost of Revenue	26.23B	19.38B	16.84B	15.53B	26.07B	19.88B	17B	14.14B	25.01B	18.59B	16.33B	14.01B	22.23B	16.82B	14.95B	12.48B	21.46B	16.04B	14.06B	13.69B	21.65B	16.42B	14.19B	12.45B	21.77B	16.25B	13.9B	12.44B	21.14B	15.37B	13.29B	11.45B	14.95B	13.96B	14.17B
Gross Profit	24.91B	21.94B	19.81B	20.95B	28.27B	25.61B	23.16B	19.33B	26.97B	24.43B	22.29B	18.64B	25.36B	23.79B	21.83B	17.79B	24.01B	22.83B	20.21B	18.22B	28.61B	27.74B	25.7B	21.29B	29.94B	26.84B	25.06B	21.28B	27.97B	24.98B	23.27B	19.3B	22.65B	22.81B	18.44B
Operating Income	7.88B	7.5B	4.44B	5.03B	6.39B	8.98B	5.34B	5.06B	7.92B	8.88B	5.02B	4.84B	6.64B	9.19B	5.55B	4.69B	6.43B	9.29B	5.34B	4.88B	6.06B	8.88B	6.13B	5.29B	6.73B	7.96B	6.04B	5.57B	5.78B	6.79B	5.41B	4.96B	4.56B	7.3B	1.58B
Interest Income	48M	39M	51M	69M	46M	52M	60M	56M	31M	19M	15M	20M	27M	29M	38M	37M	46M	62M	76M	95M	86M	86M	94M	72M	87M	83M	273M	58M	81M	68M	66M	58M	53M	66M	70M
Pretax Income	6.63B	5.02B	669M	1.59B	6.42B	10.07B	5.97B	5.1B	7.58B	9.51B	5.76B	5.1B	6.74B	9.86B	5.86B	5.18B	5.77B	9.98B	5.94B	4.95B	5.29B	9.92B	6.37B	5.21B	5.54B	9.04B	5.32B	5.4B	6.04B	6.77B	4.95B	4.82B	4.13B	6.58B	1.08B
Net Income	4.72B	3.91B	460M	976M	4.84B	7.63B	4.26B	3.61B	5.52B	6.8B	4.23B	3.47B	4.83B	7B	4.25B	3.63B	3.95B	7.04B	4.48B	3.74B	3.89B	7.04B	4.52B	3.68B	4.01B	6.38B	3.81B	3.82B	4.12B	4.7B	3.58B	3.46B	2.89B	5.22B	1.01B
Selling & General & Admin	n/a	n/a	15.39B	15.97B	8.77B	16.68B	17.85B	14.31B	7.32B	15.61B	17.3B	13.84B	8.11B	14.63B	16.31B	13.14B	8.42B	13.57B	14.88B	13.38B	13.56B	18.87B	19.57B	16B	14.5B	18.88B	19.03B	15.71B	13.14B	18.19B	17.86B	14.34B	n/a	n/a	9.54B
Research & Development	n/a	n/a	n/a	n/a	9B	n/a	n/a	n/a	8.33B	n/a	n/a	n/a	7.52B	n/a	n/a	n/a	7.34B	n/a	n/a	n/a	7.11B	n/a	n/a	n/a	7.03B	n/a	n/a	n/a	7.24B	n/a	n/a	n/a	n/a	n/a	5.79B
Other Expenses	17.02B	14.43B	-31M	192M	-25M	622M	176M	157M	99M	522M	208M	157M	25M	689M	180M	121M	134M	686M	93M	173M	92M	943M	-85M	-119M	11M	1.05B	-178M	-48M	1.33B	-103M	-236M	-11M	-70M	-47M	-108M
Operating Expenses	17.02B	14.43B	15.36B	15.92B	21.88B	16.63B	17.82B	14.27B	19.05B	15.55B	17.27B	13.79B	18.72B	14.6B	16.28B	13.1B	17.57B	13.54B	14.86B	13.35B	22.55B	18.87B	19.57B	16B	23.2B	18.88B	19.03B	15.71B	22.19B	18.19B	17.86B	14.34B	18.09B	15.51B	16.85B
Interest Expense	5M	6M	13M	4M	6M	12M	7M	4M	5M	4M	5M	4M	5M	4M	7M	2M	8M	4M	n/a	9M	8M	4M	4M	4M	16M	16M	n/a	4M	22M	7M	4M	5M	2M	7M	15M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	27.74B	n/a	n/a	n/a	26.58B	n/a	n/a	n/a	26.59B	n/a	n/a	n/a	26.01B	n/a	n/a	n/a	42.27B	n/a	n/a	n/a	42.02B	n/a	n/a	n/a	39.34B	n/a	n/a	n/a	n/a	n/a	31.28B
Cost & Expenses	43.26B	33.82B	32.21B	31.46B	47.94B	36.51B	34.81B	28.41B	44.05B	34.13B	33.59B	27.8B	40.95B	31.42B	31.23B	25.58B	39.03B	29.57B	28.92B	27.04B	44.2B	35.28B	33.76B	28.45B	44.98B	35.13B	32.93B	28.15B	43.33B	33.56B	31.16B	25.79B	33.04B	29.47B	31.01B
Income Tax Expense	1.91B	1.11B	208M	610M	1.58B	2.44B	1.71B	1.49B	2.06B	2.71B	1.54B	1.62B	1.91B	2.85B	1.61B	1.55B	1.82B	2.94B	1.46B	1.2B	1.4B	2.88B	1.85B	1.53B	1.53B	2.66B	1.51B	1.58B	1.92B	2.06B	1.37B	1.36B	1.25B	1.38B	72M
Shares Outstanding (Basic)	74.34M	n/a	74.34M	74.34M	75.04M	76.13M	76.13M	76.07M	76.52M	77.28M	77.28M	77.41M	78.01M	78.16M	78.16M	78.16M	78.16M	78.16M	78.16M	78.16M	78.16M	78.16M	78.4M	78.95M	79.07M	79.07M	79.02M	78.96M	78.93M	78.91M	78.56M	78.8M	80.25M	80.33M	80.54M
Shares Outstanding (Diluted)	74.34M	n/a	74.34M	74.34M	75.04M	76.13M	76.13M	76.07M	76.52M	77.28M	77.28M	77.41M	78.01M	78.16M	78.16M	78.16M	78.16M	78.16M	78.16M	78.16M	78.16M	78.16M	78.4M	78.95M	79.08M	79.07M	79.07M	79.04M	79.04M	79.01M	78.72M	78.86M	80.29M	80.39M	80.68M
EPS (Basic)	63.53	n/a	6.19	13.13	64.50	100.28	55.92	47.43	72.11	87.99	54.70	44.86	61.94	89.58	54.42	46.42	50.50	90.07	57.25	47.89	49.88	89.94	57.61	46.65	50.76	80.71	48.19	48.39	52.23	59.64	45.60	43.84	36.03	64.97	12.94
EPS (Diluted)	63.53	n/a	6.19	13.13	64.50	100.28	55.91	47.43	72.11	87.99	54.70	44.86	61.94	89.58	54.41	46.42	50.50	90.07	57.25	47.89	49.82	89.94	57.61	46.65	50.76	80.69	48.16	48.34	52.17	59.55	45.50	43.81	36.01	64.92	12.91
EBITDA	6.64B	5.03B	682M	5.52B	7.88B	10.09B	6.71B	6.35B	9.23B	9.51B	6.28B	6.01B	7.83B	9.86B	6.67B	5.68B	7.41B	9.98B	6.47B	5.87B	6.56B	9.93B	6.38B	6.14B	6.9B	9.05B	5.32B	5.41B	7.34B	6.78B	5.4B	4.82B	4.5B	7.15B	1.09B
EBIT	6.64B	5.03B	682M	1.59B	6.43B	10.09B	5.97B	5.1B	7.58B	9.51B	5.77B	5.1B	6.75B	9.86B	5.87B	5.18B	5.78B	9.98B	5.94B	4.96B	5.3B	9.93B	6.38B	5.22B	5.56B	7.96B	5.32B	5.41B	6.06B	6.78B	4.95B	4.82B	4.13B	6.59B	1.09B
Depreciation & Amortization	n/a	-2.48B	-3.76B	1.51B	1.51B	1.34B	1.39B	1.34B	1.34B	1.21B	1.29B	1.21B	1.21B	1.03B	1.15B	1.03B	1.03B	1.03B	1.15B	1.03B	1.03B	850.75M	847M	850.75M	178M	1.11B	82M	-148M	1.56B	-29M	-9M	-103M	-59M	-150M	-175M